Doxazosin Gastrointestinal Therapeutic System: A Review of its Use in Benign Prostatic Hyperplasia

Author： Goldsmith David R.   Plosker Greg L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.14, 2005-01, pp. : 2037-2047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Silodosin: a guide to its use in benign prostatic hyperplasia

By Keating Gillian M.   Curran Monique P.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 4, 2012-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1957-1964

Informa Healthcare

Access to resources Recommend Favorite

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1209-1211

Informa Healthcare

Access to resources Recommend Favorite

Alfuzosin: A Review of the Therapeutic Use of the Prolonged-Release Formulation Given Once Daily in the Management of Benign Prostatic Hyperplasia

By McKeage K.   Plosker G.L.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 633-653

Adis International

Access to resources Recommend Favorite

Finasteride: An Update of its Use in the Management of Symptomatic Benign Prostatic Hyperplasia

By Wilde M.I.   Goa K.L.  

Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. : 557-581

Adis International

Access to resources Recommend Favorite